Cargando…
κ-Opioid System Regulates the Long-Lasting Behavioral Adaptations Induced by Early-Life Exposure to Methylphenidate
Methylphenidate (MPH) is commonly prescribed in childhood and adolescence for the treatment of attention–deficit/hyperactivity disorders. In rodents, MPH exposure during preadolescence (postnatal days [PD] 20–35) causes decreased sensitivity to drug and natural rewards, while enhancing a negative em...
Autores principales: | Wiley, Matthew D., Poveromo, Laura B., Antapasis, John, Herrera, Carolina M., Bolaños-Guzmán, Carlos A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656574/ https://www.ncbi.nlm.nih.gov/pubmed/18923399 http://dx.doi.org/10.1038/npp.2008.188 |
Ejemplares similares
-
Adolescent Exposure to Methylphenidate Increases Impulsive Choice Later in Life
por: Abbas, Zarish, et al.
Publicado: (2017) -
Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients
por: Solleveld, Michelle M., et al.
Publicado: (2017) -
Atomoxetine/Methylphenidate Effects on Social Play Behavior
por: Millichap, J. Gordon
Publicado: (2015) -
Methylphenidate modulates motor cortical dynamics and behavior
por: Verhein, Jessica R., et al.
Publicado: (2023) -
Opioids and maternal brain–behavior adaptation
por: Swain, James E., et al.
Publicado: (2020)